Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4295272)

Published in BMC Res Notes on December 09, 2014

Authors

Daniel Caldeira1, Inês Cruz, Gonçalo Morgado, Bruno Stuart, Catarina Gomes, Cristina Martins, Isabel João, Hélder Pereira

Author Affiliations

1: Cardiology Department, Hospital Garcia de Orta, Serviço de Cardiologia, Av,Torrado da Silva, 2805-267 Almada, Portugal. dgcaldeira@hotmail.com.

Articles cited by this

Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest (2010) 10.29

A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost (1993) 7.92

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet (2010) 6.31

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med (2007) 5.29

Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score. Chest (2013) 4.71

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation (2013) 3.25

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation (2008) 2.98

Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes (2008) 2.61

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost (2011) 2.35

Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med (2007) 2.20

Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm (2009) 2.08

Warfarin for atrial fibrillation in community-based practise. J Thromb Haemost (2008) 2.05

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation. Circulation (2010) 1.68

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial. J Am Heart Assoc (2013) 1.26

Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. Thromb Res (2004) 1.22

Novel oral anticoagulants versus warfarin therapy at various levels of anticoagulation control in atrial fibrillation--a cost-effectiveness analysis. J Gen Intern Med (2013) 1.09

Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range. J Thromb Thrombolysis (2003) 1.06

Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study. Ann Pharmacother (2005) 1.02

[Anticoagulation clinics, present situation and future perspectives]. Rev Port Cardiol (2012) 0.79

[INR telemonitoring: efficacy and safety of a telemonitoring program in 453 patients]. Acta Med Port (2012) 0.78

Articles by these authors

Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol (2010) 1.73

Evaluation of hypertrophic obstructive cardiomyopathy by exercise stress echocardiography. New methodology. Rev Port Cardiol (2005) 1.61

Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart (2013) 1.49

One-year clinical outcomes of percutaneous treatment with drug-eluting balloons: results from a multicenter registry. Rev Port Cardiol (2013) 1.41

Intramyocardial dissecting haematoma: a rare complication of acute myocardial infarction. Eur J Echocardiogr (2009) 1.13

Predictive value of malnutrition markers for mortality in peritoneal dialysis patients. J Ren Nutr (2010) 0.98

Mechanism of acridine-based telomerase inhibition and telomere shortening. Biochem Pharmacol (2007) 0.96

ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues. Front Biosci (Elite Ed) (2011) 0.95

Evaluation of left ventricular outflow tract gradient during treadmill exercise and in recovery period in orthostatic position, in patients with hypertrophic cardiomyopathy. Cardiovasc Ultrasound (2008) 0.92

Physician-patient communication among Southern European cancer physicians: the influence of psychosocial orientation and burnout. Psychooncology (2005) 0.91

Exercise induced ventricular gradient in a young patient with a positive treadmill test and normal coronary arteries. Rev Port Cardiol (2002) 0.89

Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients. J Ren Nutr (2008) 0.89

Assessment of rotatory laxity in anterior cruciate ligament-deficient knees using magnetic resonance imaging with Porto-knee testing device. Knee Surg Sports Traumatol Arthrosc (2012) 0.86

[Takotsubo cardiomyopathy in a cardiology department]. Rev Port Cardiol (2012) 0.85

[Severe coronary vasospasm]. Rev Port Cardiol (2012) 0.84

Do spirituality and faith make a difference? Report from the Southern European Psycho-Oncology Study Group. Palliat Support Care (2010) 0.84

Blockade of adenosine A2A receptors prevents protein phosphorylation in the striatum induced by cortical stimulation. J Neurosci (2006) 0.83

Osteochondral transplantation using autografts from the upper tibio-fibular joint for the treatment of knee cartilage lesions. Knee Surg Sports Traumatol Arthrosc (2012) 0.82

Intellectual functioning in children with epilepsy: frontal lobe epilepsy, childhood absence epilepsy and benign epilepsy with centro-temporal spikes. Seizure (2013) 0.82

Evaluation of systolic and systo-diastolic function: the Tei index in acute myocardial infarction treated with acute reperfusion therapy--early and late evaluation. Rev Port Cardiol (2007) 0.81

Premorbid IQ influence on screening tests' scores in healthy patients and patients with cognitive impairment. J Geriatr Psychiatry Neurol (2013) 0.80

Do patients with intraventricular gradients during dobutamine stress echocardiography have intraventricular gradients with exercise testing? Rev Port Cardiol (2002) 0.79

[Anomalous origin of the right coronary artery and acute myocardial infarction: cause or coincidence?]. Rev Port Cardiol (2012) 0.79

Clinical applications of exercise stress echocardiography in the treadmill with upright evaluation during and after exercise. Cardiovasc Ultrasound (2013) 0.79

Diagnosis, pathogenesis and therapeutic targets in amyotrophic lateral sclerosis. CNS Neurol Disord Drug Targets (2010) 0.79

Native valve endocarditis due to Pichia ohmeri. Heart Vessels (2002) 0.79

[Dyspnea in aortic stenosis: appearances can be deceptive]. Rev Port Cardiol (2011) 0.78

Stunned myocardium following ischemic stroke. Case report. Cardiology (2009) 0.78

Echocardiography during treadmill exercise testing in a patient with mitral stenosis. Rev Port Cardiol (2009) 0.78

Unilateral optic neuritis as a presentation of neurobrucellosis. Pediatr Rep (2011) 0.77

The estimation of premorbid intelligence levels among Portuguese speakers: the Irregular Word Reading Test (TeLPI). Arch Clin Neuropsychol (2011) 0.77

Percutaneous coronary interventions in Europe 1992-2003. EuroIntervention (2006) 0.77

[Association between hypokalemia, malnutrition and mortality in peritoneal dialysis patients]. J Bras Nefrol (2013) 0.77

Challenging the limits of detection of sialylated Thomsen-Friedenreich antigens by in-gel deglycosylation and nano-LC-MALDI-TOF-MS. Electrophoresis (2013) 0.76

What is really a nonobstructive hypertrophic cardiomyopathy? The importance of orthostatic factor in exercise echocardiography. ISRN Cardiol (2011) 0.76

Contrast echocardiography in segmental analysis and intraventricular gradient quantification in hypertrophic cardiomyopathy. Rev Port Cardiol (2003) 0.75

Five cases of transient left ventricular apical ballooning--the experience of a Portuguese center. Rev Port Cardiol (2008) 0.75

A validation of an intelligent decision-making support system for the nutrition diagnosis of bariatric surgery patients. JMIR Med Inform (2014) 0.75

[Partial anomalous pulmonary venous return]. Rev Port Cardiol (2012) 0.75

The role of echocardiography in assessing parachute mitral valve. Rev Port Cardiol (2009) 0.75

Automated volumetry for unilateral hippocampal sclerosis detection in patients with temporal lobe epilepsy. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75

TeLPI performance in subjects with mild cognitive impairment and Alzheimer disease: a validation study. Alzheimer Dis Assoc Disord (2013) 0.75

Floating mass in the transverse aortic arch. A case report. Rev Port Cardiol (2005) 0.75

Successful management of Listeria monocytogenes pericarditis: case report and review of the literature. Acta Cardiol (2011) 0.75

Drug-eluting stents in ST-segment elevation myocardial infarction. Rev Port Cardiol (2007) 0.75

Value of treadmill exercise echocardiography in the evaluation of symptomatic hypertrophic cardiomyopathy with latent obstruction. Impact on therapeutic decisions. Rev Port Cardiol (2010) 0.75

Effusive-constrictive pericarditis: the role of noninvasive imaging. Rev Port Cardiol (2011) 0.75

Long-term follow-up of patients with deferred coronary intervention guided by measurement of fractional flow reserve. Rev Port Cardiol (2013) 0.75

A ball in the heart. Rev Port Cardiol (2010) 0.75

Thrombosis and endocarditis in prosthetic heart valves, a case report. Rev Port Cardiol (2002) 0.75

Economic evaluation of drug-eluting stents in coronary angioplasty. Rev Port Cardiol (2005) 0.75

Left pulmonary artery evaluation through transesophageal echocardiography. Rev Port Cardiol (2006) 0.75

Trends in percutaneous coronary intervention from 2004 to 2013 according to the Portuguese National Registry of Interventional Cardiology. Rev Port Cardiol (2015) 0.75

Hyponatremia--an unusual trigger of Takotsubo cardiomyopathy. Rev Port Cardiol (2011) 0.75

Five-year clinical results of coronary angioplasty with drug-eluting stents. National initiative in strategic innovation, iNOS. Rev Port Cardiol (2010) 0.75

Suspected dysfunction of a Starr-Edwards aortic prosthesis implanted 33 years ago: the role of exercise stress echocardiography. Case report. Rev Port Cardiol (2006) 0.75

[Association between body fat, inflammation and oxidative stress in hemodialysis]. J Bras Nefrol (2010) 0.75

Coronary spasm in acute myocardial infarction. Rev Port Cardiol (2004) 0.75

[Clinical predictors of infectious pulmonary tuberculosis.]. Acta Med Port (2010) 0.75

[Learning needs of parents in transition to parenthood: review of the literature]. Servir (2009) 0.75

Severe coronary milking in obstructive hypertrophic cardiomyopathy. Arq Bras Cardiol (2007) 0.75

Searching for consensus in the approach to patients with chronic lateral ankle instability: ask the expert. Knee Surg Sports Traumatol Arthrosc (2017) 0.75

[Large myxoma of the left atrium]. Rev Port Cir Cardiotorac Vasc (2009) 0.75

A case of pulmonary thromboembolism and aortic dissection: the role of echocardiography. Rev Port Cardiol (2013) 0.75

Early flow propagation velocity for assessment of diastolic function in myocardial infarction treated with acute reperfusion. Rev Port Cardiol (2008) 0.75

[Carcinoid heart - case report]. Rev Port Cardiol (2012) 0.75

Is the time in therapeutic range using the ratio of tests equivalent to the Rosendaal method? Blood Coagul Fibrinolysis (2015) 0.75

[Value of exercise echocardiography in aortic recoarctation--case report]. Rev Port Cardiol (2010) 0.75

Position statement on transcatheter aortic valve implantation in Portugal. Rev Port Cardiol (2013) 0.75

Myocardial infarction in a patient with coronary aneurysms. Rev Port Cardiol (2003) 0.75

Myocardial infarction in a patient with congenital coronary anomaly. Rev Port Cardiol (2004) 0.75

Multiple complications of endocarditis. Rev Port Cardiol (2007) 0.75

Syncope caused by severe hypotension and intraventricular gradient during dobutamine stress echocardiography. Rev Port Cardiol (2008) 0.75

Noncompaction cardiomyopathy and multiple coronary arterioventricular fistulae: 1 or 2 distinct disease entities? J Am Coll Cardiol (2011) 0.75